Cargando…

Targeting R-loop-associated ATR response in myelodysplastic syndrome

Detalles Bibliográficos
Autores principales:	Nguyen, Hai Dang, Zou, Lee, Graubert, Timothy A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498995/ https://www.ncbi.nlm.nih.gov/pubmed/31080550 http://dx.doi.org/10.18632/oncotarget.26851

Ejemplares similares

Targeting age-related inflammation in myelodysplastic syndromes
por: Mei, Yang, et al.
Publicado: (2018)

ADAR1 links R-loop homeostasis to ATR activation in replication stress response
por: Zhang, Biao, et al.
Publicado: (2023)

Transcription Factors, R-Loops and Deubiquitinating Enzymes: Emerging Targets in Myelodysplastic Syndromes and Acute Myeloid Leukemia
por: Barabino, Silvia M. L., et al.
Publicado: (2021)

Paraneoplastic Large-vessel Vasculitis Associated with Myelodysplastic Syndrome
por: Yabe, Hiroki
Publicado: (2018)

ADAR1 Prevents R-loop Accumulation-Driven ATR Pathway Activation in Ovarian Cancer
por: Cui, Hanwei, et al.
Publicado: (2022)

Myelodysplastic Syndrome: Riding the Crest of the Wave
por: Ramos, Fernando
Publicado: (2022)

Risk stratification in therapy-related myelodysplastic syndromes
por: Zeidan, Amer M.
Publicado: (2017)

Recurrent DNMT3A Mutations in Patients with Myelodysplastic Syndromes
por: Walter, Matthew J., et al.
Publicado: (2011)

From cell surface to nucleus: CCRL2 regulates response to hypomethylating agents in myelodysplastic syndromes
por: Saygin, Caner
Publicado: (2023)

ATR and p-ATR are emerging prognostic biomarkers and DNA damage response targets in ovarian cancer
por: Feng, Wenlong, et al.
Publicado: (2020)

Knowledge of Secondary Pulmonary Alveolar Proteinosis Complicated with Myelodysplastic Syndrome
por: Ishii, Haruyuki
Publicado: (2019)

Chromosome Y loss and drivers of clonal hematopoiesis in myelodysplastic syndrome
por: Baliakas, Panagiotis, et al.
Publicado: (2021)

EHA Endorsement of the European Guidelines for Myelodysplastic Syndromes, MDS-RIGHT
por: Blum, Sabine, et al.
Publicado: (2021)

Metchnikoff’s legacy: the dysplastic nature of innate immunity in myelodysplastic syndromes
por: Greenberg, Peter L.
Publicado: (2021)

SUMOylation of ATRIP potentiates DNA damage signaling by boosting multiple protein interactions in the ATR pathway
por: Wu, Ching-Shyi, et al.
Publicado: (2014)

Response to energy depletion: miR-451/AMPK loop
por: Bronisz, Agnieszka, et al.
Publicado: (2015)

Hypoosmotic stress induces R loop formation in nucleoli and ATR/ATM-dependent silencing of nucleolar transcription
por: Velichko, Artem K, et al.
Publicado: (2019)

R-loops in neuronal aging
por: Hall, Hana
Publicado: (2023)

Molecular Targeted Therapy and Immunotherapy for Myelodysplastic Syndrome
por: Lee, Paul, et al.
Publicado: (2021)

MYBL2 mRNA expression as a potential biomarker of therapeutic response to genotoxic treatments in myelodysplastic syndrome
por: Bayley, Rachel, et al.
Publicado: (2018)

Functional analysis of a chromosomal deletion associated with myelodysplastic syndromes using isogenic human induced pluripotent stem cells
por: Kotini, Andriana G, et al.
Publicado: (2015)

Novel Cellular Functions of ATR for Therapeutic Targeting: Embryogenesis to Tumorigenesis
por: Biswas, Himadri, et al.
Publicado: (2023)

Targeting miR‐126 disrupts maintenance of myelodysplastic syndrome stem and progenitor cells
por: Wang, Huafeng, et al.
Publicado: (2021)

Centromeric DNA replication reconstitution reveals DNA loops and ATR checkpoint suppression
por: Aze, Antoine, et al.
Publicado: (2016)

Integrated Genomic Analysis Implicates Haploinsufficiency of Multiple Chromosome 5q31.2 Genes in De Novo Myelodysplastic Syndromes Pathogenesis
por: Graubert, Timothy A., et al.
Publicado: (2009)

Myelodysplastic syndromes
por: Hellström Lindberg, Eva
Publicado: (2018)

Kinase-dead ATR differs from ATR loss by limiting the dynamic exchange of ATR and RPA
por: Menolfi, Demis, et al.
Publicado: (2018)

Therapeutic targeting of ATR in alveolar rhabdomyosarcoma
por: Dorado García, Heathcliff, et al.
Publicado: (2022)

p300 suppresses leukemia development in NUP98-HOXD13 driven myelodysplastic syndrome
por: Man, Na, et al.
Publicado: (2018)

EHA Endorsement of ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up for Myelodysplastic Syndromes
por: van de Loosdrecht, Arjan A., et al.
Publicado: (2022)

APOBEC3B coordinates R-loop to promote replication stress and sensitize cancer cells to ATR/Chk1 inhibitors
por: Zong, Chunyan, et al.
Publicado: (2023)

Hypertrophic pachymeningitis associated with myelodysplastic syndrome
por: Kaihatsu, Akane, et al.
Publicado: (2020)

Copper deficiency mimicking myelodysplastic syndrome
por: Dalal, Neil, et al.
Publicado: (2015)

The microenvironment in myelodysplastic syndromes: From concept to therapeutic target
por: Raaijmakers, Marc H.G.P.
Publicado: (2018)

Immune dysregulation and potential targeted therapy in myelodysplastic syndrome
por: Zhang, Xiaoying, et al.
Publicado: (2023)

LncRNA BC200/miR-150-5p/MYB positive feedback loop promotes the malignant proliferation of myelodysplastic syndrome
por: Liu, Zhaoping, et al.
Publicado: (2022)

ATR activation is regulated by dimerization of ATR activating proteins
por: Thada, Vaughn, et al.
Publicado: (2021)

Unravelling the Epigenome of Myelodysplastic Syndrome: Diagnosis, Prognosis, and Response to Therapy
por: Bond, Danielle R., et al.
Publicado: (2020)

Myelodysplastic syndromes and overlap syndromes
por: Chang, Yoon Hwan
Publicado: (2021)

Angiogenesis in myelodysplastic syndromes
por: Pruneri, G, et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_hq68rb6j38bkr5r3tb2he6jhfp